Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
biotech
boston
2
×
boston blog main
boston top stories
life sciences
national blog main
20/20 healthcare partners
ally bridge group
amgen ventures
amyotrophic lateral sclerosis
anthony despasqua
big data analytics
blackrock
casdin capital
christian angermayer
clinical trials
diabetic nephropathy
dolby family ventures
enclear therapies
eventide asset management
financing
focal segmental glomerulosclerosis
funding
gf securities
global health sciences fund
goldfinch bio
hillel bachrach
irving investors
jason camm
jay ghosh
karimah es sabar
labcentral
medical device
national top stories
peter thiel
presight capital
quark venture
quralis
schroeder adveq
series a
What
develop
diseases
2
×
new
raised
2
×
analysis
associated
bio
biotech
bring
companies
company
device
dialysis
disease
drug
drugs
employing
enclear
genetic
goldfinch
harmful
ipo
kidney
later
lead
medicines
million
nets
neuro
neurodegenerative
proteins
raises
studies
target
test
therapies
working
Language
unset
Current search:
raised
×
diseases
×
photo
×
boston
×
@xconomy.com
4 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device